2023 Volume 65 Issue 1 Pages 56-62
PuraStatⓇ—a self-assembling peptide solution—has been recently approved and marketed in Japan as a hemostatic agent for gastrointestinal endoscopy. It is an artificial synthetic peptide consisting of three amino acids: arginine (R), alanine (A), and aspartic acid (D). After coming in contact with body fluids, the peptides change from acidic to neutral, self-assembling into gel aggregates and acting as a medical device for pressure hemostasis of bleeding points. PuraStatⓇ is ineffective against spurting bleeding and can only be used for oozing. However, compared with the conventional hemostatic agents, PuraStatⓇ has the following advantages: stays as a gel for a long time at the application site; is a transparent substance easily removable by washing, and therefore, does not interfere with subsequent procedures after application; and has a low risk of infection. PuraStatⓇ can help with hemostasis of intraoperative bleeding in ESD, prevent postoperative bleeding, promote wound healing, and act as a hemostatic agent for gastrointestinal bleeding. This article outlines an endoscopic hemostatic technique using PuraStatⓇ.